Homework X - Biomaterials Science.
An extracorporeal artificial organ is a man-made device that is integrated into a human — interfacing with living tissue — to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions so the patient may return to a normal life as soon as possible. The replaced function doesn't necessarily have to be related to life support, but it often is.
IST - 4th Year - 2nd Semester - Biomedical Engineering.
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Extracorporeal Artificial Organs - Kidney & Lungs
1. Biomaterials Science – 4
th
year | 2
nd
Semester
Luís Rita | 78680
Extracorporeal Artificial Organs [HW10]
Definition + Examples
An extracorporeal artificial organ is a man-made device that is integrated into a human — interfacing with living tissue — to replace a
natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions so the patient may return
to a normal life as soon as possible. The replaced function doesn't necessarily have to be related to life support, but it often is.
Most of artificial organ technologies perform mass transfer operations to support failing or impaired organ systems. One of the oldest
and most widely employed kidney substitute is hemodialysis. Other renal assist systems can also be identified, such as hemofiltration
for the treatment of chronic renal failure and fluid overload and peritoneal dialysis (a type of hemodialysis performed inside of the
peritoneal cavity). Additionally, the blood treatment process of hemoperfusion and apheresis technologies which include plasma
exchange, plasma treatment, and cytapheresis—used to treat metabolic and immunologic diseases. In addition, blood—gas exchangers,
as required for heart-lung bypass procedures and bioartificial devices that employ living tissue in an extracorporeal circuit are also of
capital importance. Significant concerns associated to technological considerations regarding these technologies, including blood
access, anticoagulation, the effects of the extracorporeal circulation, including blood cell and humoral changes, and the biomodulation
effects of the procedure and materials of blood contacts must carefully analyzed to obtain desirable results.
Artificial Kidney | Hemodialyzer
Hemodialyzer or artificial kidney, is used to filter fluids (e.g. free water)
and wastes (e.g. urea and creatinine) from a dialysis patient’s blood.
Hemodialysis is the technique which uses the hemodialyzer to remove
excretions that kidneys partially or totally cannot. This is only one of
three renal replacement therapies (the other two being kidney
transplant and peritoneal dialysis) that can be used to achieve the same
end.
Hemodialysis can be an outpatient or inpatient therapy. Routine
hemodialysis is conducted in a dialysis outpatient facility, either a purpose
built room in a hospital or a dedicated, stand-alone clinic. Less frequently
hemodialysis is done at home.
The newest dialysis machines on the market are highly computerized and
continuously monitor an array of safety-critical parameters, including
blood and dialysate flow rates; dialysis solution conductivity,
temperature, and pH; and analysis of the dialysate for evidence of blood
leakage or presence of air. Any reading that is out of normal range triggers
an audible alarm to alert the patient-care technician who is monitoring the patient. [Fig. 1]
Artificial Lung | ECMO
Extracorporeal membrane oxygenation is an extracorporeal technique of providing both cardiac
and respiratory support to people whose heart and lungs are unable to provide an adequate
amount of gas exchange to sustain life.
This intervention has mostly been used on children, but it is seeing more use in adults with
cardiac and respiratory failure. ECMO works by removing blood from the person's body and
artificially removing the carbon dioxide and oxygenating red blood cells. Generally, it is only used
in the later treatment of a person with heart or lung failure as it is solely a life-sustaining
intervention.
Once it has been decided that ECMO will be initiated, the person is anticoagulated with
intravenous heparin and then the cannulae are inserted. ECMO support is initiated once the
cannulae are connected to the appropriate limbs of the ECMO circuit. Cannulae are usually
placed percutaneously by the Seldinger technique. The largest cannulas that can be placed in the
vessels are used in order to maximize flow and minimize pressures. Finally, following cannulation,
they are connected to the ECMO circuit and the blood flow is increased until respiratory and
hemodynamic status is stable. [Fig. 2]
Fig. 1 – Haemodialysis process overview.
Fig. 2 – Veno-arterial EMCO setup.